65
Views
14
CrossRef citations to date
0
Altmetric
Review

Adult stem cell therapy for heart failure

Pages 215-225 | Published online: 03 Mar 2005

References

  • FRIEDENSTEIN AJ: Precursor cells of mechanocytes. mt. Rev Cytol. (1976) 47:327–359.
  • WATT FM: Epidermal stem cells: markers, patterning and the control of stem cell fate. Philosophical Transactions of the Royal Society of London - Series B: Biological Sciences (1998) 353(1370):831–837.
  • PETERSEN BE, BOWEN WC, PATRENE KD et al.: Bone marrow as a potential source of hepatic oval cells. Science (1999) 284:1168–1170.
  • MCKAY R: Stem cell in the central nervous system. Science (1997) 274:69–71.
  • THOMSON JA, ITSKOVITZ-ELDOR J, SHAPIRO SS et al.: Embryonic stem cell lines derived from human blastocysts. Science (1998) 282:1145–1147.
  • KEHAT I, KENYAGIN-KARSENTI D, SNIR M et al.: Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. Clin. Invest. (2001) 108:407–414.
  • XU C, POLICE S, RAO N,CARPENTER MK: Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res. (2002) 91:501–508.
  • EDELMAN GM: Topobiology: An introduction to molecular embryology Basic books, HarperCollins Publishers, Inc., New York, USA (1988):18–21.
  • LIECHTY KW, MACKENZIE TC, SHAABAN AF et al.: Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med. (2000) 11:1282–1286.
  • PROCKOP DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science (1997) 276(5309):71–74.
  • POTTEN CS: Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philosophical Transactions of the Royal Society of London - Series B: Biological Sciences (1998) 353(1370):821–830.
  • BITTIRA B, KUANG JQ, PIQUER S, SHUM-TIM D, AL-KHALDI A, CHIU RCJ: The pathophysiological roles of bone marrow stromal cells (MSCs) in myocardial infarction. Circulation (2001) 104(Suppl.):II–523.
  • HOECHT E, KAHNERT H, GUAN K et al.: Cardiac regeneration by stem cells after myocardial infarction in transplantedhuman hearts. Circulation (2002) 106(Suppl.):II–132.
  • TERADA N, HAMAZAKI T, OKA M et al.: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature (2002) 416(6880):542–545.
  • YING QL, NICHOLS J, EVANS EP, SMITH AG: Changing potency by spontaneous fusion. Nature (2002) 416(6880):545–548.
  • VERFAILLIE CM: Stem cell plasticity. Craft (2000) 3(6):296–299.
  • WAGERS AJ, SHERWOOD RI, CHRISTENSEN JL, WEISSMANN IL: Little evidence for developmental plasticity of adult hematopoietic stem cells. Science (2002) 297:2256–2259.
  • REYES M, VERFAILLIE CM: Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann. NY Acad. Sci. (2001) 938:231–233.
  • CAPLAN Al: Mesenchymal stem cells. Orthop. Res. (1991) 9:641–650.
  • PEREIRA RE HALFORD KW, O'HARA MD et al: Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage and lung in irradiated mice. Proc. Natl. Acad. Sci. USA (1995) 92:4857–4861.
  • WANG JS, SHUM-TIMD, GALIPEAU J et al.: Marrow stromal cells for cellular cardiomyoplasty: feasibility and clinical advantages. Thorac. Cardiovasc. Slog. (2000) 120:999–1006.
  • COLTER DC, CLASS R, DIGIROLAMO CM, PROCKOP DJ: Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc. Natl. Acad. Sci. USA (2000) 97(7):3213–3218.
  • PITTENGER ME MACKAY AM, BECK SC et al.: Multilineage potential of adult human mesenchymal stem cells. Science (1999) 284:143–147.
  • PITTENGER ME MACKAY AM: Multipotential human mesenchymal stem cells. Craft (2000) 3:288–295.
  • ORLIC D, KAJSTURA J, CHIMENTL S et al.: Bone marrow cells regenerate infracted myocardium. Nature (2001) 410:701–705.
  • RINGES-LICHTENBERG SM, JAEGER MD, FUCHS M et al: Sustained improvement of left ventricular (LV) function after myocardial infarction by intravenous application of Sca-1 + Lin-/c-Kit+ bone marrow derived stem cells (Bmc).Circulation (2002) 106 (Suppl.):11–14.
  • MANGI AA, KONG D, HE H: Genetically modified mesenchymal stem cells perform in vivo repair of damaged myocardium. Circulation (2002) 106(Suppl.):II–131.
  • SAW JW, QAYUMI K, HAMBURGER JNet al.: Transplantation of highly purified lentiviral transduced SP cells from bone marrow in a porcine myocardial model. Circulation (2002) 106 (Suppl.):II–131.
  • GALINANES M, LOUBANI M, DAVIES J et al.: Safety and efficacy of transplantation of autologous bone marrow into scarred myocardium for the enhancement of cardiac function in man. Circulation (2002) 106 (Suppl.):II–463.
  • JIANG Y, JAHAGIRDAR BN, REINHARDT RL et al.: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 418(6893):41–49.
  • CAMPION DR: The muscle satellite cell: a review. Int. Rev Cytol. (1984) 87:225–251.
  • NATHANSON MA, HILFER SR, SEARLS RL: Formation of cartilage by non-chondrogenic cell types. Dev. Biol. (1978) 64:99–117.
  • MARELLI D, DESROSIERS C, ALFY M, KAO RL, CHIU RC: Cell transplantation for myocardial repair: an experimental approach. Cell Transplant. (1992) 1(6):383–390.
  • CHIU RCJ, ZIBAITIS A, KAO RL: Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann. Thome. Surg. (1995) 60:12–18.
  • CHIU RCJ: Cardiac cell transplantation: the autologous skeletal myoblast implantation for myocardial regeneration. In: Advances in Cardiac Surgery RB Karp, H Laks, AS Wechsler (Eds) (1999) 11:69–98.
  • DORFMAN J, DUONG M, ZIBAITIS Aet al.: Myocardial tissue engineering with autologous myoblast implantation. Thorac. Cardiovasc. Stag. (1998) 116:744–751.
  • REINECKE H, MACDONALD GH, HAUSCHKA SD, MURRY CE: Electromechanical coupling between skeletal and cardiac muscle: implications for infarct repair. Cell. Biol. (2000) 149:731–740.
  • TAYLOR DA, ATKINS BZ, HUNGSPREUGS P et al.: Regenerating functional myocardium: improved222performance after skeletal myoblast transplantation. Nat. Med. (1998) 4:929–933.
  • MENASCHE P, HAGEGE AA, SCORSIN M et al: Myoblast transplantation for heart failure. Lancet (2001) 357:279–280.
  • CHIU RCJ: Therapeutic cardiac angiogenesis and myogenesis: the promises and challenges on a new frontier (Editorial). Thorac. Cardiovasc. Surg. (2001) 122:851–856.
  • ATKINS BZ, LEWIS CW, KRAUS WE, HUTCHESON KA, GLOWER DD, TAYLOR DA: Intracardiac transplantation of skeletal myoblasts yields two populations of striated cells in situ. Ann. Thorac. Surg. (1999) 67:124–129.
  • REINECKE H, POPPA V, MURRY CE: Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. j Mol. Cell. Cardiology (2002) 34:241–249.
  • MACKINNEY-FREEMAN S, JACKSON KA, CAMARGO FD, FERRARI G, MAVILIO F, GOODELL MA: Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc. Natl. Acad. Sci. USA (2002) 99:1341–1346.
  • CASCIO WE, BRACKHAN J, MULLER-BORER BJ et al.: Adult-derived stem cells from the liver respond to signals from the microenvironment and transdifferentiate into cardiac myocytes in culture. Circulation (2002) 106(Suppl.):II–220.
  • BITTNER RE, SCHOFER C, WEIPOLTSHAMMER K et al.: Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystropic mdx mice. Anal Embryo]. (1999) 199:391–396.
  • CHEN J, LI Y, WANG L, ZHANG Z et al.: Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischaemia in rats. Stroke (2001) 32:1005–1011.
  • ORLIC D, KAJSTURA J, CHIMENTI S et al.: Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA (2001) 98(18):10344–10349.
  • SORGER JM, DESPRES D, HILL J et al: MRI tracking of intravenous magnetically labelled mesenchymal stem cells following myocardial infarction in rats. Circulation (2002) 106(Suppl.):11–16.
  • FUJITA J, SUZUKI Y, ANDO K et al.: Transplanted bone marrow stem cells move to the infracted myocardium and differentiate into smooth muscle cells and cardiomyocytes. Circulation (2002) 106 (Suppl.):II–132.
  • MIKI T, SAKAMOTO J, NAKANO A et al.: Mobilization of bone marrow cells by G-CSF/M-CSF improves ventricular function in the heart undergoing postinfarct remodeling. Circulation (2002)106 (Suppl.):II–15.
  • MINATOGUCHI S, TAKAMURA G, CHEN XH et al.: Myocardial infarction itself induces cardiomyocyte regeneration from bone marrow cells and postischemic G-CSF treatment improves cardiac dysfunction via acceleration of the process. Circulation (2002) 106(Suppl.):II–132.
  • FUKUHARA S, TOMITA S, OHTSU Y et al.: G-CSF promoted bone marrow cells to migrate into infracted heart and differentiate into cardiomyocytes. Circulation (2002) 106(Suppl.):11–376.
  • FUJITA J, SUZUKI Y, ANDO K et al.: G-CSF improves postinfarction heart failure by mobilizing bone marrow stem cells but GM-CSF increases the mortality by deteriorating heart function in mice. Circulation (2002) 106 (Suppl.):II–15.
  • DEVINE SM, BARTHOLOMEW AM, MAHMUD N et al.: Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp. Hematol. (2001) 29:244–255.
  • BRADSTOCK K: Wanderings of the bone-marrow stem cell. Lancet (2001) 358:5–6.
  • CHIMENTI S, BARLUCCHI L, LIMANA F et al.: Local mobilization of resident cardiac primitive cells by growth factors repairs the infracted heart. Circulation (2002) 106(Suppl.):II–14.
  • CHIU RCJ: Cellular cardiomyoplasty: the biology and clinical importance of amilieu dependent differentiation. In: Handbook of Cardiac Cell Transplantation, N Kipshidzen, PW Serruys (Eds), Martin Dunitz Ltd, London, UK (2003) (in press).
  • CAHILL KS, PITTENGER ME BYRNE BJ: Differentiation of human mesenchymal cells to cardiomyocytes by co-culture. Circulation (2002)106 (Suppl.):II–198.
  • RANGAPPA S, ENTWISTLE JWC, WECHSLER AS: Cardiomyocytes can induce human mesenchymal stem cells toexpress cardiac phenotype and genotype.Circulation (2002) 106(Suppl.):11–235.
  • TOMITA S, NAKATANI T, FUKUHARA S et al.: Bone marrow stromal cells can differentiate into cardiac lineage and contract synchronously with cardiomyocytes by direct cell-to-cell interaction 111 vitro. Presented at the 82nd Annual Meeting of the American Association for Thoracic Surgery, Washington, DC, (May 5, 2002).
  • AL-KHALDI A, ELIOPOULOS N, LACHAPELLE K, GALIPEAU J: VEGF-dependent angiogenic response induced by ex-vivo cultured marrow stromal cells. Circulation (2001) 104 (Suppl.):II–123.
  • CHEDRAWY EG, WANG JS, NGUYEN DM et al.: Incorporation and integration of implanted myogenic and stem cells into native myocardial fibres: anatomical basis for functional improvement. Thorac. Cardiovasc. Surg. (2002) 124:584–590.
  • NIKLASON LE, GAO J, ABBOTT WM et al.: Functional arteries grown in vitro. Science (1999) 284:489–493.
  • WILSON E, SUDHIR K, IVES HE: Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions.Clin. Invest. (1995) 96:2364–2372.
  • DEWEY CE BUSSOLAFI SR, GIMBRONE MA et al.: The dynamic response of vascular endothelial cells to fluid shear stress. Biome& Eng. (1981) 103:177–188.
  • KANDA K, MATSUDA T: Mechanical stress-induced orientation and ultrastructural change of smooth muscle cells cultured in three-dimensional collagen lattices. Cell Transplant. (1994) 3:481–492.
  • DOUGLAS PS, MORROW R, IOLO A, REICHEK N: Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. I Am. Coll Cardiol (1989) 13:311–315.
  • GRIESE DP, GRUMBECK B, KUNZ-SCHUGHARDT L et al: Genetic engineering of postnatal hematopoietic stem cells for gene and cell-based therapy of ischemic heart disease in rats. Circulation (2002) 106 (Suppl.)II–15.
  • YAU TM, FUNG K, FUJII T et al: Enhanced myocardial angiogenesis by gene transfer using transplanted cells. Circulation (2001) 104:1218–1222.
  • WAKITANI S, SAITO I CAPLAN AT: Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve (1995) 18:1417–1426.
  • MAKINO S, FUKUDA K, MIYOSHI S et al.: Cardiomyocytes can be generated from marrow stromal cells M vitro. Clin. Invest. (1999) 103:697–705.
  • TOMITA S, LI RK, WEISEL RD et al: Autologous transplantation of bone marrow cells improves damaged heart function. Circulation (1999) 100(Suppl. II):247–256.
  • BITTIRA B, KUANGJQ, AL-KHALDI A, SHUM-TIM D, CHIU RCJ: In vitro preprogramming of marrow stromal cells for myocardial regeneration. Ann. Thome. Slog. (2002) 74:1154–1160.
  • ROBINSON SW, CHO PW, LEVITSKY HI et al.: Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblasts. Cell Transplant. (1996) 5(1):77–91.
  • TANGY, ZHAO Q,WANG K et al: The in vivo differentiation and attribution of bone marrow derived mesenchymal stem cell in infracted myocardium in rats. Circulation (2002) 106(Suppl.):II–199.
  • WANG JS, SHUM-TIM D, CHEDRAWY E, CHIU RCJ: The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. .1 Thorac. Cardiovasc. Surg. (2001) 122:699–705.
  • SAITO T, KUANG JQ, LIN CCH, CHIU RCJ: Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction.Thorac. Cardiovasc. Surg.(2003) (in press).
  • GAO J, DENNIS JE, MUZIC RF, LUNDBERG M, CAPLAN AL: The dynamic in vivo distribution of bone-marrow derived mesenchymal stem cells after infusion. Cells Tissues Organs (2001) 169:12–20.
  • TANG Y, ZHAO Q, CHENG L: Autologous marrow stromal cell transplantation improves cardiac function after myocardial infarction in rats. Circulation (2002) 106(Suppl.):II–52.
  • THOMPSON RB, EMANI S, COLGROVE S et al.: A direct functional comparison of autologous bone marrow-derived multipotent progenitor cells and autologous skeletal myoblasts in repairing cryoinjured rabbit myocardium. Circulation (2002) 106(Suppl.):11–463.
  • YOON YS, MURAYAMA T, TKEBUCHAVA T et al: Clonally expanded bone marrow derived stem cells differentiate into multiple lineages in vitro and can attenuate myocardial dysfunction post myocardial infarction. Circulation (2002) 106 (Suppl.):II–11.
  • SIMINIAK T, KALAWSKI R, JERZYKOWSKA 0 et al.: Transplantation of autologous skeletal myoblasts in the treatment of patients with postinfarction heart failure. Early results of Phase I clinical trial. Circulation (2002) 106(Suppl.):11–636.
  • MENACHE P, HAGEGE AA, VILQUIN JT et al.: Transplantation of autologous skeletal myoblasts in patients with severe left ventricular dysfunction. A medium-term appraisal. Circulation (2002) 106 (Suppl.):11–462.
  • STAMM C, WESTPHAL B, KLEINE HD et al.: Bone marrow stem cell transplantation for myocardial regeneration in post infarction CABG patients. Circulation (2002) 106(Suppl.):11–375.
  • BEL A, AGBULUT 0, SAMUEL JL et al.:Transplantation of autologous fresh bone marrow into infracted myocardium: a word of caution. Circulation (2002)106 (Suppl.):11–463.
  • ASSMUS B, SCHACHINGER V, TEUPE C et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Circulation (2002) 106:3009–3017.
  • STAMM C, WESTPHAL B, KLEIN H-D et al.: Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet (2003) 361:45–46.
  • STRAUER BE, BREHM M, ZEUS T et al.: Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation (2002) 106:1913–1918.
  • TSE HT, KWONG Y-L, CHAN JKF et al:Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet (2003) 361:47–49.
  • LAHAM RJ, REZAEE M, GARCIA L et al.: Tissue and myocardial distribution of intracoronary, intravenous, intrapericardialand intramyocardial 125I-labelled basic fibroblast growth factor (bEGF) favor intramyocardial delivery. Am. Col. Cardiol. (2000) 35:10A.
  • ISNER JM, VALE PR, SYMES JF, LOSORDO DW: Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ. Res. (2001) 89(5):389–400.
  • HAMANO K: Preliminary result of clinical trial of therapeutic angiogenesis achieved by the implantation of self bone marrow cells for ischemic heart disease. Circulation (2001) 104(Suppl.):II-17, 11–69.
  • FUJI H, TOMITA S, HANATANI A et al: Bone marrow cell transplantation improved regional perfusion after infarction: measurement of myocardial perfusion by myocardial contrast echocardiography and histological study. Circulation (2002) 106 (Suppl.):11–375.
  • DAVANI S, MARANDIN A, KANTELIP B et al.: Transplanted mesenchymal stem cells induce angiogenesis in infracted myocardium. Circulation (2002) 106(Suppl.):11–549.
  • SIMONS M, BONOW RO,CHRONOS NA et al.: Clinical trial in coronary angiogenesis: issues, problems, consensus. An expert panel summary. Circulation (2000) 102:73–86.
  • LEE RJ, SPRINGER ML, BLANCO-BOSE WE, SHAW R, URSELL PC, BLAU HM: VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation (2000) 102(8):898–901.
  • CAPARELLI DJ, CATTANEO S, SHAKE JG et al.: Cellular cardiomyoplasty with allogeneic mesenchymal STEM cells results in improved cardiac performance in a swine model of myocardial infarction. Circulation (2001) 104 (Suppl.):11–599.
  • MAKKAR RR, PRICE M, LILL M et al.: Multilineage differentiation of transplanted allogenic mesenchymal stem cells in a porcine model of recent myocardial infarction improves left ventricular function. Circulation (2002)106 (Suppl.):11–34.
  • SAITO T, KUANG JQ, BITTIRA B, AL-KHALDI A, CHIU RCJ: Xenotransplant cardiac chimaera: immune tolerance of adult stem cells. Ann. Thorac. Surg. (2002) 74:19–24.
  • MCINTOSH K, BARTHOLOMEW A: Stromal cell modulation of the immunesystem. A potential role for mesenchymal stem cells. Graft (2000) 3:324–328.
  • MATZINGER P: The danger model: a renewed sense of self. Science (2002) 296:301–305.
  • NARULA J, HAIDER N, VIRMANI R et al.: Apoptosis in myocytes in end stage heart failure. N Engl. I Med. (1996) 335 (16): 1182–1189.
  • Y00 K-J, LI R-K, WEISEL RD, MICKLE DAG, LI G, YAU TM: Autologous smooth muscle cell transplantation improved heartfunction in dilated cardiomyopathy. Ann. Thorac. Surg. (2000) 70:859–865.
  • LEOBON B, GARCIN I, VILQUIN JT et al.: Do engrafted skeletal myoblasts contract in infracted myocardium? Circulation (2002) 106(Suppl.):II–549.
  • TAMBARA K, SAKAKIBARA Y, SAKAGUCHI G et al.: Transplanted skeletal myoblasts can fully replace the infracted myocardium when they survive in the host in large numbers. Circulation (2002) 106(Suppl.):II–549.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.